Jennifer L. Estall

8.1k citations

51 papers · 5.9k indexed · 4 hit papers · h-index 31

Physiology top 0.5%
- Adipose Tissue and Metabolism 18
Rehabilitation top 1%
Biochemistry top 1%
Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Treatment and Management 9
Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 10
- Adipokines, Inflammation, and Metabolic Diseases 5
Surgery
- Pancreatic function and diabetes 14
Molecular Biology
- Metabolism, Diabetes, and Cancer 9
- Peroxisome Proliferator-Activated Receptors 6
Cell Biology
- Endoplasmic Reticulum Stress and Disease 8

Co-authors: Bruce M. Spiegelman Daniel J. Drucker Shingo Kajimura Jorge L. Ruas Dina Laznik Bernardo Yusta Paul Cohen Jeff Ishibashi
Cited by: Physiology Rehabilitation Biochemistry
Partner nations: Canada United States France

In The Last Decade

Jennifer L. Estall

51 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2012 A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy
2011 Transcriptional Control of Adipose Lipid Handling by IRF4
2010 Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
2010 Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5

Peers

Countries citing papers authored by Jennifer L. Estall

Since Specialization

Citations

This map shows the geographic impact of Jennifer L. Estall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer L. Estall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer L. Estall more than expected).

Fields of papers citing papers by Jennifer L. Estall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer L. Estall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer L. Estall. The network helps show where Jennifer L. Estall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jennifer L. Estall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jennifer L. Estall Line = papers co-authored together Jennifer L. Estall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Is MASLD lost in translation in mice? Aysim Güneş,Jennifer L. Estall	2024	4
2	Parvalbumin gates chronic pain through the modulation of firing patterns in inhibitory neurons Haoyi Qiu,Loïs S. Miraucourt,Hugues Petitjean,Mengyi Xu,Catherine Theriault,Albena Davidova,Vanessa Soubeyre,Gaëtan Poulen,Nicolas Lonjon,Florence Vachiéry-Lahaye,Luc Bauchet,Philipa Levesque-Damphousse,Jennifer L. Estall,Emmanuel Bourinet,Reza Sharif‐Naeini	2024	5
3	IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease Aysim Güneş,Clémence Schmitt,Laurent Bilodeau,Catherine Huët,Assia Belblidia,Cindy Baldwin,Jeanne‐Marie Giard,Laurent Biertho,Annie Lafortune,Christian Couture,Angela Cheung,Bich Nguyen,Eithan Galun,Chantal Bémeur,Marc Bilodeau,Mathieu Laplante,An Tang,May Faraj,Jennifer L. Estall	2023	14
4	Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome Yannick Cyr,Valérie Lamantia,Simon Bissonnette,Mélanie Burnette,Aurèle Besse‐Patin,Annie Demers,Martin Wabitsch,Michel Chrétien,Gaétan Mayer,Jennifer L. Estall,Maya Saleh,May Faraj	2021	16
5	Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease Hannah Zhang,Mélissa Léveillé,Émilie Courty,Aysim Güneş,Bich Nguyen,Jennifer L. Estall	2020	21
6	PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments Mélissa Léveillé,Aurèle Besse‐Patin,Nathalie Jouvet,Aysim Güneş,Sarah Sczelecki,Stewart Jeromson,Naveen Khan,Cindy Baldwin,Annie Dumouchel,Jorge C. Correia,Paulo R. Jannig,Jonathan Boulais,Jorge L. Ruas,Jennifer L. Estall	2020	31
7	Loss of Furin in β-Cells Induces an mTORC1-ATF4 Anabolic Pathway That Leads to β-Cell Dysfunction Bas Brouwers,Ilaria Coppola,Katlijn Vints,Bastian Dislich,Nathalie Jouvet,Leentje Van Lommel,Charlotte Segers,Natalia V. Gounko,Lieven Thorrez,Frans Schuit,Stefan F. Lichtenthaler,Jennifer L. Estall,Jeroen Declercq,Bruno Ramos‐Molina,John W.M. Creemers	2020	22
8	LIM and cysteine-rich domains 1 (LMCD1) regulates skeletal muscle hypertrophy, calcium handling, and force Duarte M. S. Ferreira,Arthur J. Cheng,Leandro Z. Agudelo,Igor Červenka,Thomas Chaillou,Jorge C. Correia,Margareta Porsmyr‐Palmertz,Manizheh Izadi,Alicia Hansson,Vicente Martínez-Redondo,Paula Valente‐Silva,Amanda T. Pettersson-Klein,Jennifer L. Estall,Matthew M. Robinson,K. Sreekumaran Nair,Johanna T. Lanner,Jorge L. Ruas	2019	27
9	Estrogen Signals Through Peroxisome Proliferator-Activated Receptor−γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease Aurèle Besse‐Patin,Mélissa Léveillé,Daniel Oropeza,Bich Nguyen,Annik Prat,Jennifer L. Estall	2016	149
10	PGC-1 coactivators in β-cells regulate lipid metabolism and are essential for insulin secretion coupled to fatty acids Daniel Oropeza,Nathalie Jouvet,Khalil Bouyakdan,Gabrielle Perron,Léa-Jeanne Ringuette,Louis H. Philipson,Robert S. Kiss,Vincent Poitout,Thierry Alquier,Jennifer L. Estall	2015	48
11	Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation Sarah Sczelecki,Aurèle Besse‐Patin,Alexandra Abboud,Sandra Kleiner,Dina Laznik-Bogoslavski,Christiane D. Wrann,Jorge L. Ruas,Benjamin Haibe‐Kains,Jennifer L. Estall	2013	90
12	A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophybreakdown → Jorge L. Ruas,James P. White,Rajesh R. Rao,Sandra Kleiner,Kevin T. Brannan,Brooke C. Harrison,Nicholas P. Greene,Jun Wu,Jennifer L. Estall,Brian A. Irving,Ian R. Lanza,Kyle A. Rasbach,Mitsuharu Okutsu,K. Sreekumaran Nair,Zhen Yan,Leslie A. Leinwand,Bruce M. Spiegelman	2012	531
13	Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase Yaniv Lustig,Jorge L. Ruas,Jennifer L. Estall,James C. Lo,Srikripa Devarakonda,Dina Laznik,Jang Hyun Choi,Hiraku Ono,Jesper V. Olsen,Bruce M. Spiegelman	2011	87
14	Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in micebreakdown → Patrick Seale,Heather M. Conroe,Jennifer L. Estall,Shingo Kajimura,Andrea Frontini,Jeff Ishibashi,Paul Cohen,Saverio Cinti,Bruce M. Spiegelman	2010	1018
15	ErbB Signaling Is Required for the Proliferative Actions of GLP-2 in the Murine Gut Bernardo Yusta,Dianne Holland,Jacqueline A. Koehler,Marlena Maziarz,Jennifer L. Estall,Rachel R. Higgins,Daniel J. Drucker	2009	89
16	Glucagon and Glucagon-Like Peptide Receptors as Drug Targets Jennifer L. Estall,Daniel J. Drucker	2006	72
17	The Glucagon-like Peptide-2 Receptor C Terminus Modulates β-Arrestin-2 Association but Is Dispensable for Ligand-induced Desensitization, Endocytosis, and G-protein-dependent Effector Activation Jennifer L. Estall,Jacqueline A. Koehler,Bernardo Yusta,Daniel J. Drucker	2005	34
18	Lipid Raft-dependent Glucagon-like Peptide-2 Receptor Trafficking Occurs Independently of Agonist-induced Desensitization Jennifer L. Estall,Bernardo Yusta,Daniel J. Drucker	2004	38
19	Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase Bernardo Yusta,Jennifer L. Estall,Daniel J. Drucker	2002	77
20	Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling Julie A. Lovshin,Jennifer L. Estall,Bernardo Yusta,Theodore J. Brown,Daniel J. Drucker	2001	97

About Jennifer L. Estall

Jennifer L. Estall is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Cell Biology, having authored 51 papers that have together received 5.9k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (18 papers), Pancreatic function and diabetes (14 papers), Liver Disease Diagnosis and Treatment (10 papers), Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (9 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). The work is most often cited by research in Physiology (2.9k citations), Rehabilitation (418 citations) and Biochemistry (399 citations). Jennifer L. Estall has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Bruce M. Spiegelman, Daniel J. Drucker, Shingo Kajimura, Jorge L. Ruas, Dina Laznik, Bernardo Yusta, Paul Cohen, Jeff Ishibashi, Saverio Cinti and Andrea Frontini.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact